Advertisement

Topics

Pembrolizumab Plus Reduced Ipilimumab Dose Active in Advanced Melanoma

20:35 EDT 6 Aug 2017 | Cancer Networks

Standard-dose pembrolizumab with four reduced doses of ipilimumab followed by standard-dose pembrolizumab had a manageable safety profile and antitumor activity in patients with advanced melanoma.

Original Article: Pembrolizumab Plus Reduced Ipilimumab Dose Active in Advanced Melanoma

NEXT ARTICLE

More From BioPortfolio on "Pembrolizumab Plus Reduced Ipilimumab Dose Active in Advanced Melanoma"

Quick Search
Advertisement
 

Relevant Topics

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...